Drug information for CYKLOKAPRON
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
100MG/ML
Prescription
AP (Reference Drug)
TRANEXAMIC ACID
Tranexamic Acid
PHARMACIA AND UPJOHN
19281
2011-02-02 Letter
2011-01-31 Label
2009-01-30 Letter
2009-01-02 Label
2008-12-24 Letter
2001-06-18 Review
2001-03-27 Letter
1999-09-09 Letter
TABLET; ORAL
500MG
Discontinued
TRANEXAMIC ACID
Tranexamic Acid
PHARMACIA AND UPJOHN
19280
1999-09-09 Letter
1999-09-09 Review
Drug Adverse Effects information for CYKLOKAPRON
Role code
Indications
Reaction
# Reports
PS
MENORRHAGIA
DIZZINESS
1
PS
MENORRHAGIA
HYPERSENSITIVITY
1
PS
MENORRHAGIA
HYPOAESTHESIA
1
PS
MENORRHAGIA
MYOCARDIAL INFARCTION
1
C
ACQUIRED HAEMOPHILIA WITH ANTI FVIII, XI, OR XIII
CARDIOPULMONARY FAILURE
1
C
ACQUIRED HAEMOPHILIA WITH ANTI FVIII, XI, OR XIII
STAPHYLOCOCCAL SEPSIS
1
C
CONSTIPATION PROPHYLAXIS
ACCIDENTAL DEATH
1
C
CONSTIPATION PROPHYLAXIS
ROAD TRAFFIC ACCIDENT
1
C
FACTOR IX DEFICIENCY
ACCIDENTAL DEATH
1
C
FACTOR IX DEFICIENCY
ROAD TRAFFIC ACCIDENT
1
C
HAEMOPHILIA
CARDIOPULMONARY FAILURE
1
C
HAEMOPHILIA
STAPHYLOCOCCAL SEPSIS
1
C
IDIOPATHIC THROMBOCYTOPENIC PURPURA
PULMONARY EMBOLISM
1
C
MYELODYSPLASTIC SYNDROME
LUNG NEOPLASM MALIGNANT
1
C
MYELODYSPLASTIC SYNDROME
PNEUMONIA FUNGAL
1
C
MYELODYSPLASTIC SYNDROME
THROMBOCYTOPENIA
1
C
PROCOAGULANT THERAPY
ACCIDENTAL DEATH
1
C
PROCOAGULANT THERAPY
ROAD TRAFFIC ACCIDENT
1
C
PRODUCT USED FOR UNKNOWN INDICATION
CARDIOPULMONARY FAILURE
13
C
PRODUCT USED FOR UNKNOWN INDICATION
STAPHYLOCOCCAL SEPSIS
13
C
PROPHYLAXIS
LUNG NEOPLASM MALIGNANT
1
C
PROPHYLAXIS
PNEUMONIA FUNGAL
1
C
PROPHYLAXIS
THROMBOCYTOPENIA
1
Ads by Google